aanderson

Innovation Team Member, Veteran living abroad, Trader, Investor, and Entrepreneur. My tweets are "my opinions.”

[aanderson @DankTravels]

@TorayKortan @dirksstepdad 😂 🤦🏻‍♂️

[aanderson @DankTravels]

@TorayKortan

[aanderson @DankTravels]

@BCBacker Great, now it’s time for the flush.

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Bible 365 @Bible365_]

Be still

[aanderson @DankTravels]

@WillAttract This is a LIE. The Bible is God's Word and it is TRUTH.

[Josh Barzon @JoshuaBarzon]

This is your heart. It beats:

~70 times per minute.
~4,200 per hour.
~100,000 per day.
~700,000 per week.
~35 million per year.
~2.5 billion in a lifetime.

Every beat given as a gift by God, your Creator, who designed you.

Have you thanked Him for life today?

[aanderson @DankTravels]

@PilotESZ @AK57100 Just some other popular Blockchains for comparison, picked for visual representation and known popularity only. (Data came from a local Python script scraping GitHub.)

[aanderson @DankTravels]

@PilotESZ @AK57100 Some stuff you guys might find interesting....

Also check the replies to this tweet.

[aanderson @DankTravels]

@PilotESZ @AK57100

[aanderson @DankTravels]

@PilotESZ @AK57100

[aanderson @DankTravels]

@TripleXHendry @johnaldinioh89 Turns out this was closer than most people expected.

I personally had marked out 0.002.

We just hit 0.00298 which bounced off the trend line from August 25–September 24–June 22

Looks like there is a good chance of closing above the 9wk MA today.

[aanderson @DankTravels]

@i_love_tillman @johnaldinioh89 I bet you’re glad you didn’t have that $10,000 to drop on CSPR back in 2023, praise God 🙌🏼. He knows what you don’t.

[Danny @Truth_matters20]

"How do you prove that the Bible is really true?"

MacArthur:

1. The person of Jesus Christ
2. Science and archaeology
3. Scripture transforms lives.

[Trad West @trad_west_]

Birds love Jesus btw

[The General @1776General_]

I was told this was a conspiracy theory.

It’s actually a 177-page UN report.

https://t.co/KKhPPtX8Bi

[Nikita Bier @nikitabier]

In a couple hours, we'll be rolling out About This Account globally, allowing you to see the country or region where an account is based. This will be accessible by tapping the signup date on profiles.

This is an important first step to securing the integrity of the global town square. We plan to provide many more ways for users to verify the authenticity of the content they see on X.

And for those in countries where speech has penalties, we've included privacy toggles to only show your region.

This was a huge undertaking. A special thanks to the engineers who made this happen: @sandeep_rao @singhai @mingsong @striedinger @rzhao0506

[aanderson @DankTravels]

“"Before I formed you in the womb I knew you [and approved of you as My chosen instrument], And before you were born I consecrated you [to Myself as My own]; I have appointed you as a prophet to the nations." [Exo 33:12; Isa 49:1, Isa 49:5; Rom 8:29]”
(Jeremiah 1:5, AMP+)

““Before I formed you in the innermost parts I knew you, And before you came out from the womb I set you apart; I have given you as a prophet to the nations.””
(Jeremiah 1:5, LSB)

“Before I formed thee in the belly I knew thee; and before thou camest forth out of the womb I sanctified thee, and I ordained thee a prophet unto the nations.”
(Jeremiah 1:5, KJV)

“"Before I formed you in the womb I knew you; Before you were born I sanctified you; I ordained you a prophet to the nations."”
(Jeremiah 1:5, NKJV)

“"Before I formed you in the womb I knew you, before you were born I set you apart; I appointed you as a prophet to the nations."”
(Jeremiah 1:5, NIV)

““I knew you before I formed you in your mother’s womb. Before you were born I set you apart and appointed you as my prophet to the nations.””
(Jeremiah 1:5, NLT)

[aanderson @DankTravels]

@ItsAmahAdoma Holy Forever 🫶🏼

[aanderson @DankTravels]

Read all four gospels, Matthew, Mark, Luke, John, then Acts, Romans, Ephesians, Revelation, Genesis. Then maybe consider reading some of the Old Testament books like Isaiah and Ezekiel to learn that God hasn’t changed, it’s just the way we talk about Him (as a society) that changes.

If you are truly seeking, the Holy Spirit will place it on your heart or in your mind what to read (at some point). Hopefully you’ll be in tune enough to pick up on it. Best of luck, I think you’ll be surprised. The Bible is nothing like what most people (that haven’t actually read it) portray it to be.